Form 4: MaxCyte Executive Acquires Shares and Options in Recent Transaction
SEC Form 4 Filing
David I. Sandoval, General Counsel of MaxCyte, Inc., reports acquisition of common stock and stock options.
Summary
- On March 15, 2024, David I. Sandoval, General Counsel of MaxCyte, Inc., acquired 3,913 shares of common stock and 15,625 employee stock options.
- The shares were acquired at a price of $0.
- Following the transaction, Sandoval directly owns 45,913 shares of common stock and 15,625 derivative securities.
- 25% of the RSUs will vest on March 15, 2025, with the remainder vesting in three equal annual installments.
- 25% of the shares underlying the option will vest on March 15, 2025, with the remainder vesting in 36 equal monthly installments.
- Sandoval has also granted a Power of Attorney to Maher Masoud, Brian Leaf, Katie Kazem, Paul Alexander and Albert Gelin to handle SEC filings related to MaxCyte securities.
Sentiment
Score: 6
Explanation: The document primarily reflects routine transactions and legal arrangements. The acquisition of shares and options by an executive is generally viewed as a neutral to slightly positive signal, suggesting confidence in the company's prospects.
Positives
- The acquisition of shares and options by a company executive can be seen as a positive sign, indicating confidence in the company's future prospects.
Future Outlook
The vesting schedules for the RSUs and stock options are contingent upon the Reporting Person's continued service to the Issuer.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. These filings are closely watched by investors to gauge management's sentiment and confidence in the company's performance.
Comparison to Industry Standards
- Executive compensation packages often include stock options and restricted stock units to align management's interests with those of shareholders.
- Vesting schedules are a common mechanism to incentivize long-term commitment from employees.
- Power of Attorney arrangements are standard practice to streamline SEC filing processes.
Stakeholder Impact
- The reported transactions provide transparency to shareholders regarding insider activity.
- The vesting schedules for the RSUs and stock options incentivize the Reporting Person's continued service to the Issuer.
Key Dates
| Date | Description |
|---|---|
| 03/15/2024 | Date of transaction: acquisition of common stock and stock options. |
| 03/15/2025 | First vesting date for 25% of the restricted stock units and stock options. |
| 03/14/2034 | Expiration date of the employee stock options. |
| 03/18/2024 | Date of execution of the Power of Attorney. |
| 03/19/2024 | Date of filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.